NorthStar buys two additional accelerators from IBA

By staff writers

September 20, 2022 -- NorthStar Medical Radioisotope has inked a deal to buy two more Rhodotron TT300 HE electron-beam accelerators and associated beamlines from Ion Beam Applications (IBA).

NorthStar will use the accelerators at its headquarters in Beloit, WI, to expand its molybdenum-99 (Mo-99) commercial production capabilities. The company had previously purchased three Rhodotron TT300 HE electron-beam accelerators, including two in 2019 for production of Mo-99 and one in 2020 for the commercial production of actinium-225 (Ac-225).

Copyright © 2022
Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking